JP2020500871A5 - - Google Patents

Download PDF

Info

Publication number
JP2020500871A5
JP2020500871A5 JP2019529240A JP2019529240A JP2020500871A5 JP 2020500871 A5 JP2020500871 A5 JP 2020500871A5 JP 2019529240 A JP2019529240 A JP 2019529240A JP 2019529240 A JP2019529240 A JP 2019529240A JP 2020500871 A5 JP2020500871 A5 JP 2020500871A5
Authority
JP
Japan
Prior art keywords
pharmaceutically acceptable
acceptable salt
compound according
compound
seq
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2019529240A
Other languages
English (en)
Japanese (ja)
Other versions
JP7649624B2 (ja
JP2020500871A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2017/064081 external-priority patent/WO2018102616A1/en
Publication of JP2020500871A publication Critical patent/JP2020500871A/ja
Publication of JP2020500871A5 publication Critical patent/JP2020500871A5/ja
Priority to JP2022193738A priority Critical patent/JP2023029957A/ja
Application granted granted Critical
Publication of JP7649624B2 publication Critical patent/JP7649624B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2019529240A 2016-11-30 2017-11-30 副甲状腺ホルモン受容体刺激を介する、骨折をターゲティングした骨再生 Active JP7649624B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2022193738A JP2023029957A (ja) 2016-11-30 2022-12-02 副甲状腺ホルモン受容体刺激を介する、骨折をターゲティングした骨再生

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201662428492P 2016-11-30 2016-11-30
US62/428,492 2016-11-30
US201762553313P 2017-09-01 2017-09-01
US62/553,313 2017-09-01
PCT/US2017/064081 WO2018102616A1 (en) 2016-11-30 2017-11-30 Fracture targeted bone regeneration through parathyroid hormone receptor stimulation

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2022193738A Division JP2023029957A (ja) 2016-11-30 2022-12-02 副甲状腺ホルモン受容体刺激を介する、骨折をターゲティングした骨再生

Publications (3)

Publication Number Publication Date
JP2020500871A JP2020500871A (ja) 2020-01-16
JP2020500871A5 true JP2020500871A5 (enExample) 2021-01-21
JP7649624B2 JP7649624B2 (ja) 2025-03-21

Family

ID=62241919

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2019529240A Active JP7649624B2 (ja) 2016-11-30 2017-11-30 副甲状腺ホルモン受容体刺激を介する、骨折をターゲティングした骨再生
JP2022193738A Pending JP2023029957A (ja) 2016-11-30 2022-12-02 副甲状腺ホルモン受容体刺激を介する、骨折をターゲティングした骨再生

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2022193738A Pending JP2023029957A (ja) 2016-11-30 2022-12-02 副甲状腺ホルモン受容体刺激を介する、骨折をターゲティングした骨再生

Country Status (10)

Country Link
US (3) US20200317745A1 (enExample)
EP (1) EP3548012A4 (enExample)
JP (2) JP7649624B2 (enExample)
CN (1) CN110114065A (enExample)
AU (1) AU2017367699B2 (enExample)
BR (1) BR112019011070A2 (enExample)
CA (1) CA3045458A1 (enExample)
IL (1) IL266977B2 (enExample)
MX (1) MX2019006189A (enExample)
WO (1) WO2018102616A1 (enExample)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2017367699B2 (en) * 2016-11-30 2023-12-07 Purdue Research Foundation Fracture targeted bone regeneration through parathyroid hormone receptor stimulation
WO2019232283A1 (en) 2018-05-30 2019-12-05 Purdue Research Foundation Targeting anabolic drugs for accelerated fracture repair
CN110551201B (zh) * 2019-08-26 2020-04-28 杭州彗搏科技有限公司 一种新型骨形成蛋白2来源的环肽、制备方法及其应用
EP4027899A4 (en) * 2019-09-12 2023-08-16 Radius Health, Inc. METHODS OF ENHANCING SPINE FUSION USING ABALOPARATIDE
CN112646042A (zh) * 2019-10-10 2021-04-13 陕西麦科奥特科技有限公司 活性多肽化合物
CA3190513A1 (en) * 2020-09-03 2022-03-10 Jeffrey S. Bartlett Soluble alkaline phosphatase constructs and expression vectors including a polynucleotide encoding for soluble alkaline phosphatase constructs
CA3194776A1 (en) * 2020-10-26 2022-05-05 Philip S. Low Compounds,compositions and methods of use to treat bone fractures
MX2023004829A (es) * 2020-10-26 2023-07-18 Purdue Research Foundation Compuestos, composiciones y metodos de uso para tratar fusiones espinales.
WO2022149066A1 (en) * 2021-01-05 2022-07-14 Radius Health, Inc. Treatment of long bone fractures with abaloparatide
US20250295725A1 (en) * 2022-01-14 2025-09-25 Purdue Research Foundation Bone targeted treatment in osteogenesis imperfecta
WO2024246840A1 (en) * 2023-06-01 2024-12-05 Radius Health, Inc. Methods for identification and quantitation of abaloparatide and related peptide impurities
US20250127799A1 (en) * 2023-07-19 2025-04-24 Zymeron Corporation Drug conjugates for bone marrow protection

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU9103791A (en) * 1990-12-21 1992-07-22 Allelix Biopharmaceuticals Inc. Oxidation resistant variants of parathyroid hormone
CN1070500C (zh) * 1993-07-13 2001-09-05 森德克斯(美国)股份有限公司 甲状旁腺激素类似物和甲状旁腺激素相关肽:合成和治疗骨质疏松症的用途
CA2321026A1 (en) * 1998-03-09 1999-09-16 Zealand Pharmaceuticals A/S Pharmacologically active peptide conjugates having a reduced tendency towards enzymatic hydrolysis
US7057012B1 (en) * 1998-12-31 2006-06-06 The General Hospital Corporation PTH functional domain conjugate peptides, derivatives thereof and novel tethered ligand-receptor molecules
JP2000327583A (ja) * 1999-05-17 2000-11-28 Medei Sci Puraningu:Kk 骨指向性ホルモン誘導体
WO2004062588A2 (en) * 2003-01-06 2004-07-29 University Of Utah Water-soluble polymeric bone-targeting drug delivery system
PL2348114T3 (pl) * 2004-04-21 2019-08-30 Alexion Pharmaceuticals, Inc. Koniugaty do dostarczania do kości i sposób ich wykorzystania do nakierowywania białek na kość
US7863238B2 (en) * 2004-06-10 2011-01-04 Saint Louis University Proteins with an attached short peptide of acidic amino acids
US20110046059A1 (en) * 2005-09-06 2011-02-24 Zelos Therapeutics, Inc. Pharmaceutically acceptable formulations/compositions for peptidyl drugs
SI2957278T1 (sl) * 2006-10-03 2017-09-29 Radius Health, Inc. Stabilni sestavek, ki obsega PTHrP, in njegova uporaba
US7803770B2 (en) * 2006-10-03 2010-09-28 Radius Health, Inc. Method of treating osteoporosis comprising administration of PTHrP analog
ES2583002T3 (es) * 2007-04-09 2016-09-16 The Board Of Trustees Of The University Of Arkansas Proteínas de fusión de un dominio de enlazamiento a colágeno y hormona paratiroidea
PT2662448T (pt) * 2007-05-11 2017-03-29 Alexion Pharma Inc Fosfatase alcalina dirigida ao osso, kits e métodos para a utilização da mesma
EP2303288A4 (en) * 2008-05-22 2015-04-22 Univ Ramot CONJUGATES OF A POLYMER, BISPHOSPHONATE AND ANTI-ANGIOGENESIS AGENT AND USES THEREOF IN THE TREATMENT AND MONITORING OF DISEASES RELATING TO BONES
WO2012111852A1 (ja) * 2011-02-17 2012-08-23 帝人ファーマ株式会社 椎体骨折治療剤及びその評価方法
JP6033280B2 (ja) * 2011-04-22 2016-11-30 ラジウス ヘルス,インコーポレイテッド PTH、PTHrP、および関連ペプチドの薬剤送達方法
CN102824647B (zh) * 2011-06-13 2014-07-23 香港中文大学 基于小核酸药物成骨治疗的骨靶向递送系统及其制备方法
WO2014033540A2 (en) * 2012-08-28 2014-03-06 The Governors Of The University Of Alberta Parathyroid hormone, insulin, and related peptides conjugated to bone targeting moieties and methods of making and using thereof
EP3016674A4 (en) * 2013-06-23 2017-03-15 Wisconsin Alumni Research Foundation Alpha-/beta-polypeptide analogs of parathyroid hormone (pth) and method of using same
DK3265115T3 (da) * 2015-03-03 2022-09-05 Radius Health Inc Abaloparatid kombineret med alendronat til reduktion af ikke-vertebrale knoglebrud
US10279044B2 (en) * 2015-05-29 2019-05-07 Purdue Research Foundation Bone fracture repair by targeting of agents that promote bone healing
CN106039316B (zh) * 2016-05-03 2019-04-02 同济大学 一种基于多肽构建的成骨细胞靶向载体及其制备与应用
AU2017367699B2 (en) * 2016-11-30 2023-12-07 Purdue Research Foundation Fracture targeted bone regeneration through parathyroid hormone receptor stimulation
CA3194776A1 (en) * 2020-10-26 2022-05-05 Philip S. Low Compounds,compositions and methods of use to treat bone fractures

Similar Documents

Publication Publication Date Title
JP2020500871A5 (enExample)
JP7659015B2 (ja) 免疫調節剤としての1,2,4-オキサジアゾールおよびチアジアゾール化合物
JP2023029957A5 (enExample)
JP2023029957A (ja) 副甲状腺ホルモン受容体刺激を介する、骨折をターゲティングした骨再生
JP2018530560A5 (enExample)
UA125223C2 (uk) СПОЛУКИ БЕНЗО[b]ТІОФЕНУ ЯК АГОНІСТИ STING
JP2019514426A5 (enExample)
KR20170125931A (ko) 면역조절제로서의 3-치환된 1,3,4-옥사다이아졸 및 티아다이아졸 화합물
KR20170123680A (ko) 면역조절제로서의 1,3,4-옥사다이아졸 및 티아다이아졸 화합물
KR20170123338A (ko) 면역조절제로서의 치료적 환식 화합물
JP2011526886A5 (enExample)
KR20170123317A (ko) 면역조절제로서의 3-치환된-1,2,4-옥사다이아졸 및 티아다이아졸 화합물
IL240686A (en) Preparations containing cyclic peptides containing adjacent arginine residues
JP2013538564A (ja) 抗ウイルス剤
JP2017538712A5 (enExample)
PH12020551118A1 (en) Modified lipidated relaxin b chain peptides and their therapeutic use
JP2006506942A5 (enExample)
CZ100693A3 (en) Non-peptidic antagonists of bembesin
US20160168203A1 (en) Cyclic Antimicrobial Peptides
JP2017517253A (ja) ペプチド担体上の多重オリゴヌクレオチド部分
JP2011528334A5 (enExample)
US20140220074A1 (en) Toll-Like Receptor 4 (Tlr-4) Agonist Peptides For Modulating Tlr-4 Mediated Immune Response
JP2010523632A5 (enExample)
JP2009507844A5 (enExample)
JP2009533371A (ja) リソバクチンアミド類